• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,360.01 13.84
( 0.02%)
Global Indices
Nasdaq
50,746.98 -581.81
(-1.13%)
Dow Jones
7,576.82 -53.96
(-0.71%)
Hang Seng
67,369.16 -1,032.97
(-1.51%)
Nikkei 225
10,340.87 -32.64
(-0.31%)
Forex
USD-INR
95.24 0.16
(0.17%)
EUR-INR
110.83 0.16
(0.15%)
GBP-INR
128.25 0.32
(0.25%)
JPY-INR
0.60 0.00
(0.02%)

EQUITY - MARKET SCREENER

Balkrishna Industries Ltd
Industry :  Tyres
BSE Code
ISIN Demat
Book Value()
502355
INE787D01026
567.2673722
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BALKRISIND
34.82
42543.31
EPS(TTM)
Face Value()
Div & Yield %
63.2
2
0.36
 

Transgene Biotek reports consolidated net loss of Rs 0.46 crore in the March 2026 quarter
May 30,2026
Net Loss of Transgene Biotek reported to Rs 0.46 crore in the quarter ended March 2026 as against net loss of Rs 0.71 crore during the previous quarter ended March 2025. Sales declined 37.50% to Rs 0.05 crore in the quarter ended March 2026 as against Rs 0.08 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 1.65 crore in the year ended March 2026 as against net loss of Rs 0.68 crore during the previous year ended March 2025. Sales declined 19.23% to Rs 0.21 crore in the year ended March 2026 as against Rs 0.26 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.050.08 -38 0.210.26 -19
OPM %-560.00-675.00 --257.14-430.77 -
PBDT-0.41-0.69 41 -1.45-0.58 -150
PBT-0.46-0.71 35 -1.65-0.68 -143
NP-0.46-0.71 35 -1.65-0.68 -143